We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.32B
AUM Growth
+$155M
Cap. Flow
-$100M
Cap. Flow %
-1.89%
Top 10 Hldgs %
16.3%
Holding
739
New
50
Increased
312
Reduced
249
Closed
35

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$31M
2
CL icon
Colgate-Palmolive
CL
+$20M
3
MRK icon
Merck
MRK
+$18.8M
4
GLW icon
Corning
GLW
+$18.5M
5
FFIV icon
F5
FFIV
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 25.58%
2 Technology 13.62%
3 Financials 13.2%
4 Consumer Discretionary 9.51%
5 Industrials 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.82T
$110M 2.07%
3,052,888
-101,488
-3% -$3.75M
CELG
2
DELISTED
Celgene Corp
CELG
$108M 2.02%
829,286
+96,167
+13% +$11.8M
AMGN icon
3
Amgen
AMGN
$197B
$102M 1.92%
591,743
+63,181
+12% +$10.3M
GILD icon
4
Gilead Sciences
GILD
$162B
$101M 1.9%
1,426,061
-92,507
-6% -$6.16M
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$4.26T
$82.8M 1.56%
1,781,680
-813,040
-31% -$38M
AMZN icon
6
Amazon
AMZN
$2.67T
$81.8M 1.54%
1,690,240
-7,580
-0.4% -$362K
XOM icon
7
ExxonMobil
XOM
$628B
$81M 1.52%
1,002,920
+58,732
+6% +$4.81M
MSFT icon
8
Microsoft
MSFT
$2.97T
$70.4M 1.32%
1,021,550
-17,633
-2% -$1.21M
JNJ icon
9
Johnson & Johnson
JNJ
$605B
$67.3M 1.26%
508,618
-10,186
-2% -$1.3M
GE icon
10
GE Aerospace
GE
$355B
$63.4M 1.19%
490,021
+41,085
+9% +$5.63M
REGN icon
11
Regeneron Pharmaceuticals
REGN
$70.3B
$62.6M 1.18%
127,543
-43,180
-25% -$18.9M
META icon
12
Meta Platforms (Facebook)
META
$1.64T
$60M 1.13%
397,230
-156,191
-28% -$23.2M
BIIB icon
13
Biogen
BIIB
$29.7B
$59.6M 1.12%
219,601
+44,643
+26% +$11.8M
BABA icon
14
Alibaba
BABA
$283B
$57M 1.07%
404,418
+72,980
+22% +$9.01M
JPM icon
15
JPMorgan Chase
JPM
$912B
$50.9M 0.96%
557,210
+28,657
+5% +$2.47M
CL icon
16
Colgate-Palmolive
CL
$72.2B
$45.7M 0.86%
616,886
+269,381
+78% +$20M
INCY icon
17
Incyte
INCY
$23.5B
$44.9M 0.84%
356,744
+14,388
+4% +$1.83M
T icon
18
AT&T
T
$153B
$43.9M 0.83%
1,540,528
-41,077
-3% -$1.21M
MCHP icon
19
Microchip Technology
MCHP
$45B
$41.3M 0.78%
1,070,034
+143,696
+16% +$5.65M
K
20
DELISTED
Kellanova
K
$39.5M 0.74%
604,986
+460,967
+320% +$31M
MRK icon
21
Merck
MRK
$310B
$38.9M 0.73%
636,042
+309,467
+95% +$18.8M
UNH icon
22
UnitedHealth
UNH
$392B
$37.3M 0.7%
201,172
+32,800
+19% +$5.75M
VZ icon
23
Verizon
VZ
$181B
$36.6M 0.69%
819,186
-10,350
-1% -$482K
CPB icon
24
Campbell Soup
CPB
$6.63B
$36M 0.68%
689,378
+195,795
+40% +$11.1M
VRTX icon
25
Vertex Pharmaceuticals
VRTX
$122B
$35.2M 0.66%
273,420
+40,853
+18% +$4.92M

Similar funds

Candriam SCA's Q2 2017 Portfolio in Review

As of Q2 2017, Candriam SCA held 739 positions worth $5.32B, up 3% from $5.17B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA's Q2 2017 filing shows 50 new, 312 increased, 249 reduced and 35 closed positions. Its largest new stake was Raymond James Financial: 164,790 shares worth $8.81M. The largest sale was PepsiCo, an estimated $40.4M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2017 buy was Raymond James Financial: 164,790 shares worth $8.81M.
  • Candriam SCA added most to Kellanova in Q2 2017, an estimated $31M increase.
  • Candriam SCA's biggest Q2 2017 reduction was PepsiCo, cutting an estimated $40.4M.
  • Candriam SCA fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $20.4M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.32B portfolio in Q2 2017.
  • Candriam SCA opened 50 new positions and closed 35 in Q2 2017.
  • Candriam SCA's portfolio value rose 3% quarter-over-quarter to $5.32B.

Based on Candriam SCA's 13F filing for Q2 2017, filed 31 Jul 2017.